Tech Innovator Profile – 23andMe, Inc
Powered by ![]()
All the vital news, analysis, and commentary curated by our industry experts.
23andMe, Inc. (23andMe) is a personal genomics and biotechnology company that leverages machine learning (ML) technology to provide DNA analysis services.
Scope
The report provides information and insights into 23andMe, Inc.'s, including –
– Overview of the company and its product offering
– Detailed insight into its business model, company type and headquarter
– Information on funding
– Biography of top management
Reasons to Buy
– Gain insights into 23andMe’s business operations.
– Gain insights into funding and partnerships
– Gain understanding about its technology focus.
S.A. (ALM)
Lark Health
iHeartRadio
GlaxoSmithKline (GSK)
University of Queensland
Sequoia Capital
Euclidean Capital
Altimeter Capital
Wallenberg Foundation
Fidelity Management & Research Company
Casdin Capital
Table of Contents
Frequently asked questions
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Related reports
View more Technology reports